Compound Qingdai Capsules Combined with Secukinumab Versus Monotherapy for Psoriasis: A Real-World Study (ChiCTR) - Oct 16, 2026 - P4 | N=80 | Not yet recruiting | Sponsor: Gong'an County People's Hospital; Gong'an County People's Hospital
New P4 trial • Dermatology • Immunology • Psoriasis
|